Features Screener Stocks Charts
Sign In Sign Up

Fortis Healthcare (India) Ltd. Key Financial Ratios

NSE:FORTIS | HEALTHCARE

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Profitability Margins

2-year trend showing gross, operating, and net profit margins

FY 2024 - FY 2025

Fortis Healthcare (India) Ltd.'s net profit margin of 10.3% in FY2025 reflects moderate profitability, with operating margin at 16.2% and gross margin at 76.7%.

Understanding Profitability Margins

In FY 2025, Fortis Healthcare (India) Ltd. posted a gross margin of 76.7%, an operating margin of 16.2%, a net margin of 10.3%. Gross Margin = (Revenue - COGS) / Revenue; Operating Margin = EBIT / Revenue; Net Margin = Net Income / Revenue. Typical healthy ranges: Gross 20-40%, Operating 10-20%, Net 5-10%+. Consistent or improving margins indicate strong competitive positioning.

Company Performance

2-year trend showing revenue, gross profit, and net profit

FY 2024 - FY 2025

Fortis Healthcare (India) Ltd.'s revenue grew 13.3% to 78.50B and net profit grew 25.4% to 8.09B YoY in FY2025, indicating healthy business momentum.

Understanding Company Performance

In FY 2025, Fortis Healthcare (India) Ltd.'s revenue grew by 13.3% year-over-year. Revenue is total income from operations. Gross Profit is revenue minus cost of goods. Net Profit is the bottom line after all expenses. Consistent growth across all three signals a healthy, expanding business.

Return on Equity (ROE)

2-year trend showing shareholder returns

FY 2024 - FY 2025

Fortis Healthcare (India) Ltd.'s ROE of 8.8% in FY2025 indicates below-average shareholder returns.

Understanding Return on Equity (ROE)

In FY 2025, Fortis Healthcare (India) Ltd. reported an ROE of 8.8%. ROE = (Net Income / Shareholders' Equity) x 100. Measures how efficiently the company turns equity into profit. Above 15% is generally strong; above 25% is excellent. Very high ROE may signal high leverage — check alongside debt levels.

Net Income vs Free Cash Flow

2-year trend comparing profitability with cash generation

FY 2024 - FY 2025

Fortis Healthcare (India) Ltd.'s FCF/NI ratio of 0.71x in FY2025 indicates reasonable cash generation relative to profits.

Understanding Net Income vs Free Cash Flow

In FY 2025, Fortis Healthcare (India) Ltd.'s free cash flow trailed net income. Free Cash Flow = Operating Cash Flow - Capital Expenditure. When FCF exceeds net income, it suggests high-quality, cash-backed earnings. Persistent gaps may indicate aggressive accounting or heavy capex needs.

Net Income vs Operating Cash Flow

2-year trend comparing profitability with cash from operations

FY 2024 - FY 2025

Fortis Healthcare (India) Ltd.'s OCF/NI ratio of 1.76x in FY2025 indicates strong cash collection and working capital efficiency.

Understanding Net Income vs Operating Cash Flow

In FY 2025, Fortis Healthcare (India) Ltd.'s operating cash flow exceeded net income. Operating Cash Flow is the actual cash from core operations. OCF exceeding net income signals strong cash collection. OCF trailing net income may indicate aggressive revenue recognition or working capital issues.

Leverage Ratios

Measure a company's financial leverage, liquidity, and ability to meet financial obligations.

Current Ratio Analysis

2-year trend showing short-term liquidity position

FY 2024 - FY 2025

Fortis Healthcare (India) Ltd.'s current ratio of 0.92x in FY2025 indicates tight liquidity — may face difficulty meeting short-term obligations.

Understanding Current Ratio

In FY 2025, Fortis Healthcare (India) Ltd. reported a current ratio of 0.92. Current Ratio = Current Assets / Current Liabilities. Measures short-term liquidity. A ratio of 1.5-3.0 is generally healthy; below 1.0 signals liquidity risk; above 3.0 may indicate underutilized assets.

Interest Coverage Ratio Analysis

2-year trend showing ability to service debt

FY 2024 - FY 2025

Fortis Healthcare (India) Ltd.'s interest coverage ratio of 6.9x in FY2025 indicates comfortable debt servicing capacity.

Understanding Interest Coverage Ratio

In FY 2025, Fortis Healthcare (India) Ltd. reported an interest coverage ratio of 6.9x. Interest Coverage = EBIT / Interest Expense. Shows how many times operating profit covers interest payments. Above 5x is comfortable; below 1.5x signals potential difficulty servicing debt.

Debt-to-Equity Ratio Analysis

2-year trend showing financial leverage and capital structure

FY 2024 - FY 2025

Fortis Healthcare (India) Ltd.'s debt-to-equity ratio of 0.27x in FY2025 reflects a conservative, low-leverage capital structure.

Understanding Debt-to-Equity Ratio

In FY 2025, Fortis Healthcare (India) Ltd. reported a debt-to-equity ratio of 0.27. Debt-to-Equity = Total Debt / Total Equity. Below 1.0 is conservative; 1.0-2.0 is moderate; above 2.0 indicates higher financial risk. Capital-intensive industries naturally carry higher ratios.

Total Debt Analysis

2-year trend showing total debt with year-over-year changes

FY 2024 - FY 2025

Fortis Healthcare (India) Ltd.'s debt increased 114.3% YoY in FY2025 — rising leverage demands close monitoring.

Understanding Total Debt

In FY 2025, Fortis Healthcare (India) Ltd.'s total debt increased by 114.3% year-over-year. Total Debt includes short-term debt, long-term loans, debentures, and capital leases. YoY changes (shown as percentages) reveal whether the company is leveraging up or deleveraging.

Shares Outstanding

Year-over-year change in diluted shares outstanding

Fortis Healthcare (India) Ltd.'s diluted shares remained virtually unchanged in FY2025.

Over 2 years (FY2024–FY2025), diluted shares remained essentially unchanged at 754.59M.

Understanding Shares Outstanding

In FY 2025, Fortis Healthcare (India) Ltd.'s diluted shares decreased by 0.0% year-over-year. Diluted Shares accounts for stock options, warrants, and convertibles. Positive YoY change means dilution (red); negative means buybacks (green). Consistent dilution above 5% annually is a red flag.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: FY 2025